Effect of human umbilical cord blood derived CD34+ cells transpantation on the neurological recovery of rats with cerebral ischemia

Hai-ying Liu,Jian-feng Li,Hong-jun Li,Qing-jun Zhang,Zhong-chao Han

DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.03.008

2008-01-01

Abstract:Aim: CD34+ stem cells are unique primitive cell populations with the characters of self-renewal, multi-differentiation and reconstruction of hematopoietic and immune function. Recent studies have indicated that it has significant effect on myocardial ischemia and physically vascular occlusion. It is known that for a long time the clinical effects of cerebral ischemia were poor, so, we observe the neurological functional recovery after transplanting human umbilical cord blood derived CD34+ cells into rats with middle cerebral artery occlusion (MCAO), and detect the survival, migration and neural differentiation of CD34+ cells. Methods: The experiment was performed in the Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College since May 2002. 1 Sixty adult male SD rats of 250-350 g were provided by the Fourth Department of Academy of Military Medical Sciences. All experimental procedures were accorded with the standards of animal ethics. Human umbilical cord blood was provided by cord blood stem cell bank of Tianjin and its application was agreed by the puerperas. 2 Rats were randomly divided into three groups (n =20): CD34+ cells group, in which CD34+ cells were transplanted 24 hours after the establishment of models of MCAO using intraluminal thread approach; normal saline group, in which normal saline was injected 24 hours after the establishment of models; sham operation group, in which only models of MCAO were established. 3 Functional outcome measurements were performed using the modified neurological severity score after transplantation. Meanwhile, the survival and migration of BrdU-labeled CD34+ cells and the expression of astrocytic marker-GFAP (glial fibriliary acidic protein) and the neuron marker-NeuN (neuronal nuclei) were detected by immunohistochemical and immunofluorescent staining. Results: 1 There was no significant difference in the modified neurological severity score 24 hours after transplantation between CD34+ cell group and other groups (P > 0.05). From 1 to 4 weeks after operation, the neurological function of three groups showed improvement in different degrees, but the rats in CD34+ group had the best recovery (P < 0.05). 2 The infarct volume of rats in CD34+ group had no significant decrease compared with the other two groups. 3 Transplanted CD34+ cells survived in cerebral tissues of rats, and partial of them expressed GFAP or NeuN maker and migrated towards ischemic tissue. Conclusion: CD34+ cells can survive, migrate and differentiate towards astrocytes or neurons after transplantation. Moreover, they improve the neurological recovery after MCAO.